But retatrutide does something remarkable
Attina G, Mastrangelo S, Ruggiero A
Regulatory status is subject to change
He works with doctors who monitor his hormone levels, adjust protocols as needed, and ensure he's approaching optimization safely
The authors themselves described it as a small preliminary study.[15] A 2025 pilot report described intravenous administration to two healthy adults at doses up to 20 mg, with no measurable changes in cardiac, hepatic, renal or thyroid biomarkers and no reported adverse effects.[16] Two individuals cannot characterise uncommon reactions, immunogenicity, long-term toxicity, reproductive safety or oncological risk
These combined effects make them particularly valuable for studies focused on injury recovery, inflammation, and tissue stability